Niagen Bioscience Inc (NAGE) compared with its closest peers (DFTX, SCL, OLPX, EPC, USNA): P/E 16.0 vs industry 17.2. Peer set by Business model: Branded Consumer (CPG, Staples, Beauty, Alcohol, Pet, Nicotine); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | $6.03B | — |
| Stepan Company (SCL) | $1.45B | 23.1 |
| Olaplex Holdings, Inc. (OLPX) | $1.40B | -134.0 |
| Edgewell Personal Care Company (EPC) | $1.32B | 38.4 |
| USANA Health Sciences, Inc. (USNA) | $250.36M | 33.4 |
| Waldencast plc (WALD) | $147.15M | -0.9 |
| FitLife Brands, Inc. (FTLF) | $93.07M | 15.5 |
| Solesence, Inc. Common Stock (SLSN) | $69.96M | 79.8 |
| biote Corp. (BTMD) | $46.23M | 7.0 |
| Natural Alternatives International, Inc. (NAII) | $13.14M | -1.5 |
| Stock P/E | 16.0 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| vs Sector | -26.4% |
| vs Industry | -6.9% |
NAGE overview · NAGE earnings · NAGE financials · NAGE KPIs · NAGE investor relations · NAGE ownership · NAGE filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.